Soluble CD95

Thesis

Cover

Titlepage

Abbreviations

Contents

1 General Introduction

2 Prevention of apoptosis by monoclonal antibodies against CD95

3 Patients with Systemic Lupus Erythematosus with high plasmalevels of sFas risk relapse

4 Increase in soluble CD95 concentrations in patients with severe SLE, but not their first degree relatives

5 The relation of soluble CD95 levels with disease activity in Systemic Lupus Erythematosus Patients

6 Do elevated levels of serum soluble Fas contribute to the persistence of activated lymphocytes in Systemic Lupus Erythematosus?

7 Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections

8 Soluble CD95 levels in renal transplant recipients

9 The coagulant-inflammatory axis in the baboon response to E.coli: effects of tissue factor pathway inhibitor on hemostatic balance, the cytokine network and the release of the apoptosis marker sFas.

10 Summary and general discussion

References

Samenvatting

Cover